Stay updated on COVID-19 Cardiovascular Manifestations Clinical Trial
Sign up to get notified when there's something new on the COVID-19 Cardiovascular Manifestations Clinical Trial page.

Latest updates to the COVID-19 Cardiovascular Manifestations Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedAdded a Locations section with Texas; removed the Texas Locations entry and the HHS Vulnerability Disclosure; updated page revision from v3.3.2 to v3.3.3.SummaryDifference0.2%

- Check28 days agoNo Change Detected
- Check42 days agoChange DetectedThe page shows a minor revision from v3.3.1 to v3.3.2 with no substantive changes to study details, eligibility criteria, or outcomes. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check49 days agoChange DetectedRevision: v3.3.1 was added and v3.2.0 was removed on the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check56 days agoChange DetectedThe page removed the notice about government funding and operating status; it previously warned that information may not be up to date due to appropriations. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check71 days agoChange DetectedThe page updates seem limited to visual layout and UI refinements; there are no changes to the study description, endpoints, eligibility criteria, or contact information. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check99 days agoChange DetectedPage now includes an official operating-status notice and updates version to v3.2.0, replacing v3.1.0.SummaryDifference3%

Stay in the know with updates to COVID-19 Cardiovascular Manifestations Clinical Trial
Enter your email address, and we'll notify you when there's something new on the COVID-19 Cardiovascular Manifestations Clinical Trial page.